AACR logo

More articles from Cancer Therapeutics Insights

Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
Kan He, Xingnan Zheng, Lin Zhang, Jian Yu

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2559-2568; DOI: 10.1158/1535-7163.MCT-13-0284
Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide
Marcus Eich, Wynand Paul Roos, Teodora Nikolova, Bernd Kaina

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2529-2540; DOI: 10.1158/1535-7163.MCT-13-0136
The Cannabinoid WIN 55,212-2 Decreases Specificity Protein Transcription Factors and the Oncogenic Cap Protein eIF4E in Colon Cancer Cells
Sandeep Sreevalsan, Stephen Safe

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2483-2493; DOI: 10.1158/1535-7163.MCT-13-0486
Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction
Yan Long, Wen-Bin Tsai, Medhi Wangpaichitr, Takashi Tsukamoto, Niramol Savaraj, Lynn G. Feun, Macus Tien Kuo

Molecular Cancer Therapeutics Nov 2013, 12 (11) 2581-2590; DOI: 10.1158/1535-7163.MCT-13-0302
Combining Erlotinib and Cetuximab Is Associated with Activity in Patients with Non–Small Cell Lung Cancer (Including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutations
Jennifer J. Wheler, Apostolia M. Tsimberidou, Gerald S. Falchook, Ralph G. Zinner, David S. Hong, Jansina Y. Fok, Siqing Fu, Sarina A. Piha-Paul, Aung Naing, Razelle Kurzrock

Molecular Cancer Therapeutics Oct 2013, 12 (10) 2167-2175; DOI: 10.1158/1535-7163.MCT-12-1208
Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A
Haiquan Lu, Xinqun Li, Zhongguang Luo, Jie Liu, Zhen Fan

Molecular Cancer Therapeutics Oct 2013, 12 (10) 2187-2199; DOI: 10.1158/1535-7163.MCT-12-1245
PI3K Stimulates DNA Synthesis and Cell-Cycle Progression via Its p55PIK Regulatory Subunit Interaction with PCNA
Guihua Wang, Xiaonian Cao, Senyan Lai, Xuelai Luo, Yongdong Feng, Xianmin Xia, Paul M. Yen, Jianping Gong, Junbo Hu

Molecular Cancer Therapeutics Oct 2013, 12 (10) 2100-2109; DOI: 10.1158/1535-7163.MCT-12-0920
Chemotherapy Counteracts Metastatic Dissemination Induced by Antiangiogenic Treatment in Mice
Alessandra Rovida, Vittoria Castiglioni, Alessandra Decio, Valentina Scarlato, Eugenio Scanziani, Raffaella Giavazzi, Marta Cesca

Molecular Cancer Therapeutics Oct 2013, 12 (10) 2237-2247; DOI: 10.1158/1535-7163.MCT-13-0244
Subtype-Specific MEK-PI3 Kinase Feedback as a Therapeutic Target in Pancreatic Adenocarcinoma
Olga K. Mirzoeva, Eric A. Collisson, Peter M. Schaefer, Byron Hann, Yun K. Hom, Andrew H. Ko, W. Michael Korn

Molecular Cancer Therapeutics Oct 2013, 12 (10) 2213-2225; DOI: 10.1158/1535-7163.MCT-13-0104
Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism
Tracy Murray-Stewart, Christin L. Hanigan, Patrick M. Woster, Laurence J. Marton, Robert A. Casero

Molecular Cancer Therapeutics Oct 2013, 12 (10) 2088-2099; DOI: 10.1158/1535-7163.MCT-13-0418

Main menu

User menu

Search

More articles from Cancer Therapeutics Insights

Pages

Articles

Info for

About MCT